Early Increase in Extrasynaptic NMDA Receptor Signaling and Expression Contributes to Phenotype Onset in Huntington's Disease Mice

@article{Milnerwood2010EarlyII,
  title={Early Increase in Extrasynaptic NMDA Receptor Signaling and Expression Contributes to Phenotype Onset in Huntington's Disease Mice},
  author={Austen J Milnerwood and Clare M. Gladding and Mahmoud A. Pouladi and Alexandra Mansell Kaufman and Rochelle M. Hines and Jamie D. Boyd and Rebecca W Y Ko and Oana Cristina Vasuta and Rona K Graham and Michael R. Hayden and Timothy H. Murphy and Lynn A. Raymond},
  journal={Neuron},
  year={2010},
  volume={65}
}

Figures from this paper

Neuroprotective strategies for NMDAR-mediated excitotoxicity in Huntington’s Disease
TLDR
NMDAR-mediated excitotoxicity is identified as a key player in HD pathogenesis and points to various excitOToxicity-focused targets as potential future preventative therapeutics for HD.
Suppressing aberrant GluN3A expression rescues synaptic and behavioral impairments in Huntington's disease models.
TLDR
It is shown that mutant HTT redirects an intracellular store of juvenile NMDARs containing GluN3A subunits to the surface of striatal neurons by sequestering and disrupting the subcellular localization of the endocytic adaptor PACSIN1, which is specific for Glun3A.
SAP97‐mediated rescue of NMDA receptor surface distribution in a neuronal model of Huntington's disease
TLDR
High‐resolution data reveals plasticity in surface NMDAR localization driven by mutant HTT and identifies the similar but independent roles of SAP97 N‐terminal isoforms in maintaining normal synaptic function in pathological states.
Extrasynaptic NMDA receptor-induced tau overexpression mediates neuronal death through suppressing survival signaling ERK phosphorylation
TLDR
Results indicate that tau overexpression mediates the excitatory toxicity induced by E-NMDAR activation through inhibiting ERK phosphorylation.
DAPK1 Promotes Extrasynaptic GluN2B Phosphorylation and Striatal Spine Instability in the YAC128 Mouse Model of Huntington Disease
TLDR
It is demonstrated that dysregulation of DAPK1 occurs early in the YAC128 HD mouse model, and contributes to elevated extrasynaptic GluN2B S1303 phosphorylation, validating DAPk1 as a potential target for synaptic protection in HD and warranting further development of D APK1-targeted therapies for neurodegeneration.
Neuroprotective strategies for NMDAR-mediated excitotoxicity in Huntington’s Disease
TLDR
NMDAR-mediated excitotoxicity is identified as a key player in HD pathogenesis and points to various excitOToxicity-focused targets as potential future preventative therapeutics for HD.
Differential Synaptic and Extrasynaptic Glutamate-Receptor Alterations in Striatal Medium-Sized Spiny Neurons of Aged YAC128 Huntington’s Disease Mice
Huntington’s disease (HD) is a late-onset, slowly progressing neurodegenerative disorder caused by an expansion of glutamine repeats. The YAC128 mouse model has been widely used to study the
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 95 REFERENCES
Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin
TLDR
Treatment of transgenic mice expressing a yeast artificial chromosome containing 128 CAG repeats with low-dose memantine blocks extrasynaptic (but not synaptic) NMDARs and ameliorates neuropathological and behavioral manifestations, and offers a rational therapeutic approach for protecting susceptible neurons in Huntington's disease.
N-Methyl-d-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease
Mitochondrial Sensitivity and Altered Calcium Handling Underlie Enhanced NMDA-Induced Apoptosis in YAC128 Model of Huntington's Disease
TLDR
The results suggest that the CAG repeat length influences the mechanism by which mHtt enhances NMDAR-mediated excitotoxicity, and the enhanced NMDA-induced apoptosis in YAC128 MSNs is predominantly determined by augmented mitochondrial sensitivity to Ca2+-induced activation of the mPT.
Polyglutamine-Modulated Striatal Calpain Activity in YAC Transgenic Huntington Disease Mouse Model: Impact on NMDA Receptor Function and Toxicity
TLDR
The cumulative effect of increasing huntingtin polyglutamine length is to enhance MSN sensitivity to excitotoxicity at least in part by calpain-mediated cell death signaling.
Altered NMDA Receptor Trafficking in a Yeast Artificial Chromosome Transgenic Mouse Model of Huntington's Disease
TLDR
PolyQ length-dependent enhancement of peak NMDAR current density by mhtt is reported in cultured MSNs, but not cortical neurons, from the yeast artificial chromosome (YAC) transgenic HD mouse model, suggesting that altered N MDAR trafficking may underlie potentiation of NMDar-mediated current and toxicity in the YAC72 HD mouse models.
In Vivo Evidence for NMDA Receptor-Mediated Excitotoxicity in a Murine Genetic Model of Huntington Disease
TLDR
The first direct in vivo evidence of NR2B–NMDAR-mediated excitotoxicity in the context of HD is tested, consistent with previous suggestions that direct and/or indirect interactions of mutant huntingtin with NMDARs are a proximate cause of neurodegeneration in HD.
Corticostriatal synaptic function in mouse models of Huntington's disease: early effects of huntingtin repeat length and protein load
TLDR
These findings demonstrate multiple perturbations to corticostriatal synaptic function in HD mice, furthering the understanding of the early effects of the HD mutation that may contribute to cognitive dysfunction, mood disorders and later development of more serious dysfunction.
NMDA receptor function in mouse models of Huntington disease
TLDR
Findings indicate that alterations in NMDA receptor function may predispose striatal neurons to excitotoxic damage, leading to subsequent neuronal degeneration and underscore the functional importance of NMDA receptors in HD.
...
1
2
3
4
5
...